OWC Pharmaceutical Research Corp (OWCP)

[BAMF31]

I believe the January date mentioned would have been if proposal 2 was passed. However, neither proposal passed so there is no chance of a RS unless the company files another Schedule 14A. It was difficult to hear and understand the speaker but should be clarified when the official results are released.



1. To authorize our Board of Directors to effect one reverse stock split of our outstanding Common Stock, $0.00001 par value per share, at any ratio up to 1-for-700, at such time as our Board of Directors shall determine, in its sole discretion, before December 31, 2020;


2. To approve one or more adjournments to the Meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Meeting cast in favor of Proposal No. 1;